Advanced Cancers: Clinical Trials

6 trials for Advanced Cancers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 26Terminated 6
Phase 32Terminated 2
Phase 11Terminated 1

Follow Advanced Cancers: new trials by email Literature Review of Advanced Cancers trials Research Report on Advanced Cancers

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
Ilorasertib - Advanced Cancers
Phase 2TerminatedM.D. Anderson Cancer Center122016-08-052023-07-17
Sublingual Fentanyl for the Management of Breakthrough Pain
Fentanyl Sublingual Spray (FSS), Questionnaires, Mental Ability Tests - Advanced Cancers
Phase 2TerminatedM.D. Anderson Cancer Center62016-02-022021-05-18
The Use of Light Therapy for Managing Sleep Disturbances in Patients With Advanced Cancer
Bright Light Therapy, Dim Red Light Therapy, Questionnaires - Advanced Cancers
Phase 2 / Phase 3TerminatedM.D. Anderson Cancer Center122011-06-012019-03-26
Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer
Atorvastatin, Fish Oil Supplement, Placebo - Advanced Cancers
Phase 2 / Phase 3TerminatedM.D. Anderson Cancer Center22011-01-012012-08-07
Phosphatidylinositol 3 Kinase and Mammalian Target of Rapamycin (PI3K-mTOR) in Advanced Cancer Patients
Temsirolimus - Advanced Cancers
Phase 1 / Phase 2TerminatedM.D. Anderson Cancer Center442009-04-012016-08-25
Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)
Ridaforolimus Tablet, Ridaforolimus Intravenous (IV) Infusion - Advanced Cancers
Phase 2TerminatedMerck Sharp & Dohme LLC72009-02-012019-02-18

Narrower conditions

Neoplasm Metastasis (2)  ·  Agnosia (1)  ·  Anxiety Disorders (1)  ·  Breast Neoplasms (1)  ·  Colorectal Neoplasms (1)  ·  Depression (1)  ·  Fatigue (1)  ·  Head and Neck Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Parasomnias (1)  ·  Recurrence (1)  ·  Sarcoma (1)  ·  Urogenital Neoplasms (1)

Broader conditions

Neoplasms (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Neoplastic Processes (2)  ·  Nervous System Diseases (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Breast Diseases (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Disease Attributes (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Surveys and Questionnaires (2)  ·  Atorvastatin (1)  ·  Fatty Acids, Omega-3 (1)  ·  Ultraviolet Therapy (1)  ·  ilorasertib (1)  ·  ridaforolimus (1)  ·  temsirolimus (1)

Sponsors

M.D. Anderson Cancer Center (5)  ·  Merck Sharp & Dohme LLC (1)

Countries

United States (5)

Top investigators

Ara Vaporciyan, MD, BS (1)  ·  Daniel Karp, MD (1)  ·  David S. Hong, MD (1)  ·  Rony Dev, DO (1)  ·  Suresh Reddy, MD (1)